Top section
Top section
Bpifrance pounces to sell Technip block after shares leap
Europe’s self-proclaimed investment banking champions are playing to their strengths, but remain far behind US peers
The most successful investment banks must strive for excellence in managing people
More articles
More articles
More articles
-
JP Morgan has named Simone Haslinger and Jonas Troeber as the co-heads of its equity capital markets business in Australia and New Zealand.
-
European financial regulators have bowed to pressure from investment firms and their trade bodies, and look set to weaken the requirements of the Sustainable Finance Disclosure Regulation, a central part of the EU's Sustainable Finance Action Plan. -
Huge demand for exposure to biotech companies among US equity investors is continuing to drive UK firms to list on the other side of the Atlantic through an IPO on the Nasdaq. On Thursday, Immunocore, a late-stage biotech firm focused on T-cell technology, priced an enlarged offering on the exchange and, on Friday, UK healthcare investor Syncona announced it was exploring a US IPO for one of its portfolio companies.
-
Hipgnosis Songs Fund, a London-listed investment trust focused on music royalties, has closed its latest share sale, raising £75m.
-
Medical device manufacturer New Horizon Health has pulled in early demand to cover its Hong Kong IPO multiple times over, according to a source familiar with the matter.
-
Thai Beverage is preparing to spin off and list its brewery business, BeerCo, on the Singapore Exchange in a deal expected to raise as much as $2bn.
Sub-sections
shared comment list
